These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 33219204)

  • 21. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
    Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
    Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of aberrant p73 promoter methylation in patients with myelodysplastic syndrome].
    Zhao YS; Yang R; Gu SC; Guo J; Zhang X; Wu LY; Li X; Chang CK
    Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):847-51. PubMed ID: 23384909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS.
    Zhao X; Tian X; Kajigaya S; Cantilena CR; Strickland S; Savani BN; Mohan S; Feng X; Keyvanfar K; Dunavin N; Townsley DM; Dumitriu B; Battiwalla M; Rezvani K; Young NS; Barrett AJ; Ito S
    Br J Haematol; 2016 Nov; 175(3):427-439. PubMed ID: 27433923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Research progress on mechanism of MDS transformation into AML].
    Wang LL; Gao C; Chen BA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):254-9. PubMed ID: 21362264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring.
    Xu F; Li X; Wu L; Zhang Q; Yang R; Yang Y; Zhang Z; He Q; Chang C
    Ann Hematol; 2011 Jun; 90(6):643-53. PubMed ID: 21125401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetics of progression from MDS to secondary leukemia.
    Menssen AJ; Walter MJ
    Blood; 2020 Jul; 136(1):50-60. PubMed ID: 32430504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The myelodysplastic syndrome as a prototypical epigenetic disease.
    Issa JP
    Blood; 2013 May; 121(19):3811-7. PubMed ID: 23660859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Methylation status of LINE-1 sequences in patients with MDS or secondary AML].
    Römermann D; Hasemeier B; Metzig K; Schlegelberger B; Länger F; Kreipe H; Lehmann U
    Verh Dtsch Ges Pathol; 2007; 91():338-42. PubMed ID: 18314632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms of the progression of myelodysplastic syndrome to secondary acute myeloid leukaemia and implication for therapy.
    Dan C; Chi J; Wang L
    Ann Med; 2015 May; 47(3):209-17. PubMed ID: 25861829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CpG island methylator phenotype of myelodysplastic syndrome identified through genome-wide profiling of DNA methylation and gene expression.
    Zhao X; Yang F; Li S; Liu M; Ying S; Jia X; Wang X
    Br J Haematol; 2014 Jun; 165(5):649-58. PubMed ID: 24601943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypermethylation of DLX4 predicts poor clinical outcome in patients with myelodysplastic syndrome.
    Zhang TJ; Zhou JD; Yang DQ; Wang YX; Yao DM; Ma JC; Wen XM; Guo H; Lin J; Qian J
    Clin Chem Lab Med; 2016 May; 54(5):865-71. PubMed ID: 26485746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter hypermethylation analysis in myelodysplastic syndromes: diagnostic & prognostic implication.
    Solomon PR; Munirajan AK; Tsuchida N; Muthukumarasamy K; Rathinavel A; Selvam GS; Shanmugam G
    Indian J Med Res; 2008 Jan; 127(1):52-7. PubMed ID: 18316853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic basis of myelodysplastic syndromes.
    Ogawa S
    Proc Jpn Acad Ser B Phys Biol Sci; 2020; 96(3):107-121. PubMed ID: 32161209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA methylation sequencing shows different gene expression signatures for response to azacytidine therapy in high-grade myelodysplastic syndromes.
    Gulei D; Moisoiu V; Kegyes D; Drula R; Iluta S; Tigu AB; Nistor M; Jitaru C; Bancos A; Rotariu P; Popovici C; Dima D; Tomai R; Rus I; Constantinescu C; Munteanu R; Cenariu D; Sezerman U; Zdrenghea M; Cermak J; Einsele H; Ghiaur G; Tomuleasa C
    J Cell Mol Med; 2024 Sep; 28(18):e70078. PubMed ID: 39334509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LEP promoter methylation in the initiation and progression of clonal cytopenia of undetermined significance and myelodysplastic syndrome.
    Kaastrup K; Gillberg L; Mikkelsen SU; Ørskov AD; Schöllkopf C; Mortensen BK; Porse B; Hansen JW; Grønbæk K
    Clin Epigenetics; 2023 May; 15(1):91. PubMed ID: 37237325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide analysis toward the epigenetic aetiology of myelodysplastic syndrome disease progression and pharmacoepigenomic basis of hypomethylating agents drug treatment response.
    Siamoglou S; Boers R; Koromina M; Boers J; Tsironi A; Chatzilygeroudi T; Lazaris V; Verigou E; Kourakli A; van IJcken WFJ; Gribnau J; Symeonidis A; Patrinos GP
    Hum Genomics; 2023 Apr; 17(1):37. PubMed ID: 37098643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic changes in FOXO3 and CHEK2 genes and their correlation with clinicopathological findings in myelodysplastic syndromes.
    Sharifi MJ; Zaker F; Nasiri N; Yaghmaie M
    Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):214-219. PubMed ID: 32217071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical Implications on ZO-1 Gene Methylation in Myelodysplastic Syndrome Progression].
    Kang HY; Wang XR; Gao L; Wang W; Li MY; Wang LL; Wang CB; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):746-9. PubMed ID: 26117030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome.
    Wang H; Wang XQ; Xu XP; Lin GW
    Leuk Res; 2010 May; 34(5):598-604. PubMed ID: 19853913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes.
    Benetatos L; Hatzimichael E; Dasoula A; Dranitsaris G; Tsiara S; Syrrou M; Georgiou I; Bourantas KL
    Leuk Res; 2010 Feb; 34(2):148-53. PubMed ID: 19595458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.